NATIONAL HEALTHCARE CORP·4

May 6, 4:10 PM ET

LAROCHE RICHARD F JR 4

4 · NATIONAL HEALTHCARE CORP · Filed May 6, 2026

Research Summary

AI-generated summary of this filing

Updated

NHC Director Richard LaRoche Exercises Stock Options for $537K

What Happened

  • Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), exercised stock options on 2026-05-05 to acquire 7,500 common shares at an exercise price of $71.64 per share, for a total cash outlay of $537,300. The filing also reports a contemporaneous derivative disposition of 7,500 shares at $0.00 (no cash proceeds reported).

Key Details

  • Transaction date: 2026-05-05; Filing date: 2026-05-06 (appears timely).
  • Acquired: 7,500 shares via option exercise at $71.64/share (total $537,300).
  • Disposed: 7,500 derivative shares at $0.00 (no cash proceeds shown).
  • Shares owned after the transaction: not specified in the excerpt provided.
  • Footnote: The options were granted under the 2020 Omnibus Equity Incentive Plan on May 6, 2021; the grant and exercise are reported as exempt from Section 16(b) under Rule 16b-3(d).

Context

  • This filing documents an options exercise (insider acquisition of shares). The report does not show an open-market sale of the shares for cash. The $0.00 derivative disposition is reported in the Form 4 but the filing does not specify whether shares were surrendered or withheld to satisfy exercise costs or tax obligations.

Insider Transaction Report

Form 4
Period: 2026-05-05
Transactions
  • Exercise/Conversion

    Common Stock - Held in my name or my wife's name

    [F1]
    2026-05-05$71.64/sh+7,500$537,300213,260 total
  • Exercise/Conversion

    Option to Purchase Common Stock [2021 Grant]

    [F1]
    2026-05-057,5000 total
    Exercise: $71.64From: 2022-05-06Exp: 2026-05-05Common Stock (7,500 underlying)
Holdings
  • Option to Purchase Common Stock [2022 Grant]

    Exercise: $69.19From: 2023-05-05Exp: 2027-05-04Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2023 Grant]

    Exercise: $55.75From: 2025-05-04Exp: 2028-05-03Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2024 Grant]

    Exercise: $96.03From: 2024-05-09Exp: 2029-05-08Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2025 Grant]

    Exercise: $94.66From: 2026-05-08Exp: 2030-05-07Common Stock (7,500 underlying)
    7,500
Footnotes (1)
  • [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Signature
/s/ Richard LaRoche|2026-05-06

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4